Express Pharma - Express Pharma

Transaction marks entry into global naturals market and sets up manufacturing and sales hub in Western Europe

Company scores 91 out of 100; included in Sustainability Yearbook 2026 for third consecutive year

Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million annual market sales

Findings released ahead of Shingles Action Week show low awareness and limited doctor-patient discussions on risk and vaccination

Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data with Indian participation

Initiative positions obesity as a chronic disease and highlights role of doctors in evidence-based care

Company secures final approval for ANDA across four strengths; cumulative USFDA ANDA approvals reach 235

Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based in Mumbai

Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device

Event highlights intelligent automation, industry collaboration, and next-generation motion control technologies